Showing results (151-160 of 202) with videos related to
Sort By:
Pageof 21
Biochemistry|October 17, 1998
Evolution of enzymatic activities in the enolase superfamily: characterization of the (D)-glucarate/galactarate catabolic pathway in Escherichia coliB K Hubbard, M Koch, D R Palmer, et al.Biochemistry|October 17, 1998
Evolution of enzymatic activities in the enolase superfamily: crystal structure of (D)-glucarate dehydratase from Pseudomonas putidaA M Gulick, D R Palmer, P C Babbitt, et al.Epidemiology and Infection|April 10, 2014
Injection site infections and injuries in men who inject image- and performance-enhancing drugs: prevalence, risks factors, and healthcare seekingV D Hope, J McVeigh, A Marongiu, et al.Journal of Clinical Microbiology|December 8, 2006
Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypesA Chawla, G Murphy, C Donnelly, et al.Journal of Viral Hepatitis|May 12, 2010
Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spotsV D Hope, M Hickman, S L Ngui, et al.Ethnicity & Health|July 11, 2000
Surveillance for the impact in the UK of HIV epidemics in South AsiaS Cliffe, J Mortimer, C McGarrigle, et al.Communicable Disease and Public Health|July 27, 2001
Test of HIV incidence shows continuing HIV transmission in homosexual/bisexual men in England and WalesG Murphy, J V Parry, S B Gupta, et al.Journal of Accident & Emergency Medicine|November 1, 1996
The rising prevalence of HIV-1 infection in patients attending an inner city accident and emergency departmentM C Poznansky, J Walters, A Cruikshank, et al.Drug and Alcohol Dependence|August 1, 2017
Low levels of hepatitis C diagnosis and testing uptake among people who inject image and performance enhancing drugs in England and Wales, 2012-15V D Hope, J McVeigh, J Smith, et al.Journal of Clinical Pathology|October 1, 1983
Report of a joint DMRQC/Organon field trial to detect hepatitis A IgM by ELISAE M Supran, J Craske, R J Hart, et al.Pageof 21